Cindy, PhD – Chief Science Officer, BOD
As Chief Science Officer of Digipath Labs, Dr. Cindy Orser is creating a replicable testing environment with validated protocols to ensure cannabis and cannabis-based products are safe. She is also developing standards and biomarkers to clearly distinguish products derived from specific cannabis strains concomitant with determining the bioavailability of the cannabinoids found in the product.
Dr. Orser draws from over 20 years of experience innovating in both academia and private industry. She holds 18 issued patents and has authored 41 peer-reviewed publications. She received her BS in Botany from Montana State University in Bozeman, and was awarded a PhD from the University of California, Berkeley, in Plant Pathology and Genetics. Dr. Orser is the founder of five biotech companies including Adlyfe, Cellphire, Big Sky Biosystems, ASDx Biosystems, and iPDx Biosciences. She has consulted for the molecular and medical diagnostics industry as well as the federal government. For five years, Dr. Orser served as Corporate Senior Scientist and Head of the Biodefense/ Biotechnology Initiative at Areté Associates in Washington, DC, and she was also a tenured professor of biochemistry and bacteriology at the University of Idaho.